As awareness about ulcers grows, the world is experiencing an increasing demand for high quality Anti-Ulcerant treatment. Today, GTI is investing in research, product development and manufacturing facilities to meet this challenge.
GTI is expanding to become a leading supplier of the Anti-Ulcerant Sucralfate API around the world
Sucralfate
With a focus on Anti-Ulcerant, GTI is constructing a state-of-the-art facility for Sucralfate API at Jhagadia, Gujarat. When completed, the USFDA approved and GMP compliant plant will begin manufacturing of Sucralfate API for use in Suspension and Tablet Formulations. This investment will establish GTI as the only company in India to have an integrated process of Sucralfate API from KSM to API. While adhering to local and global regulatory requirements, we will market and distribute globally from our new facility.
Sucralfate: Uses And Application
Treat ulcers of the upper gastrointestinal tract, peptic ulcer disease
Prevent recurrent ulcers after the ulcer has healed
Relieve or prevent ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs)
